TM Owner Taiho Oncology
Trifluridine/Tipiracil 20mg/8.19mg Tablet
Global Shipping : Reliable Global Distribution Network
Express Delivery : Priority Shipping for Every Order
Secure Payments : Trusted Payment Protection System
Secure Handling
24/7 Worldwide Support
Global Access
Worldwide Access to Health
Cold-Chain Expert
Excellence in Cold-Chain
Trusted Supply
Certified Medical Supply
Indications & Clinical Uses
- "Trifluridine/Tipiracil" is a molecule-combination descriptor rather than a marketed brand name; no product is listed under this exact name on DailyMed or the FDA database.
- The approved medicine containing this fixed combination is Lonsurf (trifluridine 20mg with tipiracil 8.19mg film-coated tablets), manufactured by Taiho Pharmaceutical and marketed in the US by Taiho Oncology, and this content is sourced from the Lonsurf label.
- Lonsurf is a cytotoxic antimetabolite combination used in adults with metastatic colorectal cancer previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and an anti-EGFR therapy if RAS wild-type, given alone or together with bevacizumab.
- It is also approved for metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines including a fluoropyrimidine, a platinum agent, and either a taxane or irinotecan.
- Lonsurf is prescribed and monitored by a cancer specialist but taken by the patient at home.
Side Effects
- Lonsurf has no boxed warning, but it commonly causes bone marrow suppression: neutropenia, anaemia and thrombocytopenia affect more than 1 in 10 patients, along with fatigue, nausea, decreased appetite, diarrhoea, vomiting, abdominal pain and fever.
- Severe (Grade 3-4) neutropenia occurs in roughly a third to half of patients and can lead to febrile neutropenia or life-threatening sepsis; contact your care team urgently for fever, chills, unusual bleeding or bruising, or signs of infection.
- Blood counts are checked before starting and again partway through every treatment cycle so the dose can be adjusted or delayed if counts fall too low.
- Persistent or severe diarrhoea and vomiting should also be reported promptly, as they can cause dehydration; stay well hydrated and seek help if symptoms do not settle with standard anti-diarrhoeal or anti-emetic measures.
Precautions & Warnings
- Lonsurf must not be started in patients with moderate or severe liver impairment, and the dose should be reduced in severe kidney impairment.
- Complete blood counts are required before every cycle and mid-cycle to guide dose modification, interruption or discontinuation for severe myelosuppression.
- Because it can harm an unborn baby, females of reproductive potential should use effective contraception during treatment and for at least six months afterwards, and males with partners who could become pregnant should use contraception for at least three months after the last dose; it should not be used in pregnancy or while breastfeeding.
- Report any fever, signs of infection, severe fatigue, or gastrointestinal symptoms immediately.
- There is no specific driving restriction, but tell your oncology team about fatigue or dizziness.
- Tablets should be taken within one hour after finishing breakfast and dinner.
Avoid Interactions
- Trifluridine and tipiracil are not metabolised by cytochrome P450 enzymes, so classic CYP-based drug interactions are not expected, but you should still tell your oncologist and pharmacist about every prescription medicine, over-the-counter product and supplement you use.
- Extra caution is needed with other medicines that suppress bone marrow function, since combining them can worsen neutropenia, anaemia or thrombocytopenia.
- Live vaccines should generally be avoided during chemotherapy because of a weakened immune response.
- Alcohol may add to nausea and fatigue and is best limited.
- Because Lonsurf can cause significant gastrointestinal side effects, discuss any other medicines that irritate the stomach or bowel, such as NSAIDs, with your care team before combining them.
References
Frequently Asked Questions
Lonsurf combines trifluridine and tipiracil to treat adults with metastatic colorectal cancer who have already tried standard chemotherapy, and metastatic gastric or gastroesophageal junction cancer after at least two earlier treatment lines. It slows tumour growth by blocking cancer-cell DNA production, and your oncologist prescribes it once other options have been used.
Lonsurf tablets are taken by mouth twice daily, within one hour after breakfast and dinner, for five days followed by two days off, repeated for two weeks, then one week with no tablets, in 28-day cycles. Always take the exact dose your oncologist prescribes for your body surface area.
The most common effects are low blood counts (neutropenia, anaemia, thrombocytopenia), tiredness, nausea, reduced appetite, diarrhoea and fever. Severe neutropenia can lead to serious infection, so contact your care team urgently for fever, chills, or signs of infection. Blood tests before and during each cycle check for this.
Avoid live vaccines and other bone-marrow-suppressing medicines without checking with your oncologist first, since combining them can worsen low blood counts. Tell your care team about every medicine and supplement you take. Lonsurf is not safe in pregnancy, so effective contraception is required during treatment and for months afterwards.
Skip a missed dose and take your next scheduled dose at the usual time; do not double up. If you vomit after a dose, do not retake it that day. Keep a record of missed or vomited doses and tell your oncology team, since it may affect blood-count monitoring.
No. Lonsurf can harm an unborn baby, so women who could become pregnant must use effective contraception during treatment and for at least 6 months after the last dose; men need contraception for 3 months after. It should not be used while breastfeeding. Discuss family planning with your oncologist first.

Trusted & Reliable – Your Partner in Global Distribution.
We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.